Clinical Focus
Business Focus
Spotlight
CE/CME
7 New Drugs for Primary Care: Q3 2020
The end of another quarter means a new list of FDA-approved drugs for conditions treated in primary care. Are you up-to-date? Click through to find out.
As another quarter rounds out, a new batch of drugs have been approved by the US Food and Drug Administration for conditions often seen in primary care. Scroll through the slides below to find details on a first-in-class topical androgen receptor inhibitor for the treatment of acne; a novel attachment inhibitor for adults with multidrug-resistant HIV-1 infection; and 5 more.
Related Videos
Related Content
